USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Alignedbio AB

USPTO PatentsView assignee record - 5 granted patents across 11 technology areas, active 2021–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B82Y (SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

16.6

Avg claims per patent

5-year filing velocity

The verdict

Alignedbio holds 5 US patents across 11 technology areas, rank #44,486 of 50,000 tracked assignees.

#44,486
of 50,000 US assignees by volume: Top 42%
by Innovation Score (37.9/100): 16.6
avg claims per patent

Portfolio overview

Alignedbio AB has been granted 5 US utility patents between 2021 and 2023, placing Alignedbio AB at rank #44,486 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.6 claims per patent with primary concentration in B82Y (SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES). As a Foreign Corporation, Alignedbio AB is one of the more focused assignees in the PatentsView dataset. By volume, Alignedbio sits between Alere Technologies Gmbh (5 patents, rank #44,482) and Allflex Australia PTY Limited (5 patents, rank #44,490) - the closest US assignees by grant volume. The composite Innovation Score of 37.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2023, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Alignedbio AB's 16.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Alignedbio AB against peers pursuing similar technology classes.

Alere

5
Alerje

5
ALEX IS THE BEST

5
Algra S P A

5
Alite

5
Allanson Lighting

5
Alldata

5
Allflex Australia…

5
Alignedbio AB ◀

5

What this shows Alignedbio holds 5 patents at rank #44,486, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alignedbio

By rank, the assignees closest to #44,486 in granted patent volume.

Leaders in B82Y (Specific USES OR Applications OF Nanostructures)

Other assignees with the most granted patents in Alignedbio's primary technology class.

Alignedbio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Alignedbio AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	40.0%
2022	2	40.0%
2023	1	20.0%

Which technologies does Alignedbio AB patent most?

B82Y - SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES 3

C30B - SINGLE-CRYSTAL GROWTH ; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL ; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE ; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WI 2

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 2

C23C - COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL 2

H10D - INORGANIC ELECTRIC SEMICONDUCTOR DEVICES 2

Y02E - REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION 2

H10K - ORGANIC ELECTRIC SOLID-STATE DEVICES 2

B05D - PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL 2

H10F - INORGANIC SEMICONDUCTOR DEVICES SENSITIVE TO INFRARED RADIATION, LIGHT, ELECTROMAGNETIC RADIATION OF SHORTER WAVELENGTH OR CORPUSCULAR RADIATION 2

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 1

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

Top 11 of 11 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Where it ranks

Overall rank by patents

#44,486

Across all tracked assignees

Innovation Score

37.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Alignedbio AB hold?

Alignedbio AB holds 5 US granted patents filed between 2021 and 2023, spanning 11 technology areas.

What is Alignedbio AB's Innovation Score?

Alignedbio AB has an Innovation Score of 37.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Alignedbio AB focus on?

Alignedbio AB's top technology area is B82Y (SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES) with 3 patents. The company has filed patents in 11 CPC subclasses total.

Is Alignedbio AB's patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Alignedbio AB.

What does claim depth mean for Alignedbio AB's patents?

Alignedbio AB's patents average 16.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Alignedbio AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Alignedbio's 5 grants land it in the top 42% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Alignedbio ranks #44,486 of 50,000. Top 50 holders
Most of this portfolio concentrates in B82Y - see who else leads that technology area. B82Y leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.